Alambic Investment Management, L.P. - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 55 filers reported holding PSYCHEMEDICS CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q1 2019$163,000
-27.9%
11,636
-1.0%
0.07%
+8.1%
Q2 2018$226,000
-19.9%
11,751
-10.8%
0.06%
+59.0%
Q1 2018$282,000
-2.4%
13,181
-6.3%
0.04%
+11.4%
Q4 2017$289,000
-30.4%
14,070
-37.5%
0.04%
-22.2%
Q3 2017$415,000
-46.0%
22,527
-26.9%
0.04%
-52.1%
Q2 2017$769,000
+28.8%
30,827
+3.5%
0.09%
+27.0%
Q1 2017$597,000
+104.5%
29,794
+151.9%
0.07%
+42.3%
Q4 2016$292,00011,8260.05%
Other shareholders
PSYCHEMEDICS CORP shareholders Q3 2018
NameSharesValueWeighting ↓
Tieton Capital Management, LLC 250,388$3,974,0004.46%
QUANTUM CAPITAL MANAGEMENT 63,246$1,004,0000.58%
Mill Road Capital Management LLC 14,896$236,0000.30%
Gs Investments, Inc. 15,800$250,746,0000.21%
RBF Capital, LLC 87,917$1,395,0000.18%
North Star Investment Management Corp. 85,282$1,353,0000.18%
CRAWFORD INVESTMENT COUNSEL INC 297,675$4,724,0000.16%
Uniplan Investment Counsel, Inc. 145,677$2,311,0000.16%
DEPRINCE RACE & ZOLLO INC 282,186$4,478,0000.13%
Moors & Cabot, Inc. 37,932$605,0000.10%
View complete list of PSYCHEMEDICS CORP shareholders